Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch Repair-Deficient/Microsatellite Instability-High (dMMR/MSI-H) Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma：A Randomized, Non-comparative Phase 2 Study

Clinical trial NCT07266025 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07266025
Sponsor: Shanghai Zhongshan Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Adenocarcinoma Gastroesophageal Adenocarcinoma Mismatch Repair Deficient or MSI-High Solid Tumors Immunotherapy

Start date: 2026-01-30
Primary completion: 2030-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.